Ontology highlight
ABSTRACT: Background
Rectal neuroendocrine tumors (R-NET) represent the most frequent of gastroenteropancreatic neuroendocrine neoplasms (NEN-GEP) according to the United States Surveillance, Epidemiology, and End Results database. With an annual percentage of occurrence increasing to 8.2% of all rectal neoplasms, R-NET affect less than 2% and are reported in only 0.05% to 0.07% of patients undergoing colorectal cancer (CRC) screening. The primary objective of this study was to assess the risk factors associated with R-NET greater than 10 mm. As a secondary objective, it was also aimed to evaluate the response to endoscopic treatment.Methods
This was a retrospective study, using data collected through the analysis of medical records of colonoscopies performed from January 2008 to Dec
SUBMITTER: de Castro JSL
PROVIDER: S-EPMC8975358 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature